Adalimumab-induced systemic lupus erythematosus: A case report and review of the literature

Adalimumab is a tumor necrosis factor inhibitor that has been widely used since the early 2000s for the treatment of psoriasis and psoriatic arthritis. All tumor necrosis factor inhibitors have been identified as causative agents in drug induced lupus, particularly etanercept and infliximab. There h...

Full description

Saved in:
Bibliographic Details
Published in:SAGE open medical case reports 2023-01, Vol.11, p.2050313X231193077
Main Authors: Landells, Fiona M, Vender, Ronald
Format: Article
Language:English
Subjects:
JCMS Case Report
Lupus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c500t-c29163b68b1618758770c8fd18c005e659fc9fefe0d82a912de1107cc858ec0d3
cites cdi_FETCH-LOGICAL-c500t-c29163b68b1618758770c8fd18c005e659fc9fefe0d82a912de1107cc858ec0d3
container_end_page
container_issue
container_start_page 2050313X231193077
container_title SAGE open medical case reports
container_volume 11
creator Landells, Fiona M
Vender, Ronald
description Adalimumab is a tumor necrosis factor inhibitor that has been widely used since the early 2000s for the treatment of psoriasis and psoriatic arthritis. All tumor necrosis factor inhibitors have been identified as causative agents in drug induced lupus, particularly etanercept and infliximab. There have been few reported cases of systemic lupus erythematosus induced by adalimumab, many more are attributable to treatment with etanercept or infliximab. We present the case of a patient with long-standing psoriasis and psoriatic arthritis who was successfully treated with adalimumab, but developed anti-tumor necrosis factor-induced lupus.
doi_str_mv 10.1177/2050313X231193077
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c01aed3eeaf447488b488de234d776ba</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2050313X231193077</sage_id><doaj_id>oai_doaj_org_article_c01aed3eeaf447488b488de234d776ba</doaj_id><sourcerecordid>2920184911</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-c29163b68b1618758770c8fd18c005e659fc9fefe0d82a912de1107cc858ec0d3</originalsourceid><addsrcrecordid>eNp1kU9r3DAQxUVpaEKSD9BLEfTsdMayLbmXsoT-CQR6SaDQg5Cl8caLbW0lOWW_fbXdNE0oPQgNT29-M-gx9hrhAlHKdyXUIFB8KwViK0DKF-xkrxV78eWT-pidx7gBAIRWNSBesWMha4WI1Qn7vnJmHKZlMl0xzG6x5HjcxUTTYPm4bJfIKezSHU0m-bjE93zFrYnEA219SNzMLpf3A_3kvufZx8chUTBpCXTGjnozRjp_uE_Z7aePN5dfiuuvn68uV9eFrQFSYcsWG9E1qsMGVd5MSrCqd6gsQE1N3fa27akncKo0LZaOEEFaq2pFFpw4ZVcHrvNmo7dhmEzYaW8G_VvwYa1NSIMdSVtAQ04Qmb6qZKVUl4-jUlROyqYzmfXhwNou3UTO0pyCGZ9Bn7_Mw51e-3uNUGVKVWXC2wdC8D8Wiklv_BLm_AG6bEtAVbWI2YUHlw0-xkD94wgEvc9X_5Nv7nnzdLfHjj9pZsPFwRDNmv6O_T_xFzaNrng</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920184911</pqid></control><display><type>article</type><title>Adalimumab-induced systemic lupus erythematosus: A case report and review of the literature</title><source>SAGE Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Landells, Fiona M ; Vender, Ronald</creator><creatorcontrib>Landells, Fiona M ; Vender, Ronald</creatorcontrib><description>Adalimumab is a tumor necrosis factor inhibitor that has been widely used since the early 2000s for the treatment of psoriasis and psoriatic arthritis. All tumor necrosis factor inhibitors have been identified as causative agents in drug induced lupus, particularly etanercept and infliximab. There have been few reported cases of systemic lupus erythematosus induced by adalimumab, many more are attributable to treatment with etanercept or infliximab. We present the case of a patient with long-standing psoriasis and psoriatic arthritis who was successfully treated with adalimumab, but developed anti-tumor necrosis factor-induced lupus.</description><identifier>ISSN: 2050-313X</identifier><identifier>EISSN: 2050-313X</identifier><identifier>DOI: 10.1177/2050313X231193077</identifier><identifier>PMID: 37581114</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>JCMS Case Report ; Lupus</subject><ispartof>SAGE open medical case reports, 2023-01, Vol.11, p.2050313X231193077</ispartof><rights>The Author(s) 2023</rights><rights>The Author(s) 2023.</rights><rights>The Author(s) 2023. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023 2023 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-c29163b68b1618758770c8fd18c005e659fc9fefe0d82a912de1107cc858ec0d3</citedby><cites>FETCH-LOGICAL-c500t-c29163b68b1618758770c8fd18c005e659fc9fefe0d82a912de1107cc858ec0d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423444/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2920184911?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,21966,25753,27853,27924,27925,37012,44590,44945,45333,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37581114$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Landells, Fiona M</creatorcontrib><creatorcontrib>Vender, Ronald</creatorcontrib><title>Adalimumab-induced systemic lupus erythematosus: A case report and review of the literature</title><title>SAGE open medical case reports</title><addtitle>SAGE Open Med Case Rep</addtitle><description>Adalimumab is a tumor necrosis factor inhibitor that has been widely used since the early 2000s for the treatment of psoriasis and psoriatic arthritis. All tumor necrosis factor inhibitors have been identified as causative agents in drug induced lupus, particularly etanercept and infliximab. There have been few reported cases of systemic lupus erythematosus induced by adalimumab, many more are attributable to treatment with etanercept or infliximab. We present the case of a patient with long-standing psoriasis and psoriatic arthritis who was successfully treated with adalimumab, but developed anti-tumor necrosis factor-induced lupus.</description><subject>JCMS Case Report</subject><subject>Lupus</subject><issn>2050-313X</issn><issn>2050-313X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kU9r3DAQxUVpaEKSD9BLEfTsdMayLbmXsoT-CQR6SaDQg5Cl8caLbW0lOWW_fbXdNE0oPQgNT29-M-gx9hrhAlHKdyXUIFB8KwViK0DKF-xkrxV78eWT-pidx7gBAIRWNSBesWMha4WI1Qn7vnJmHKZlMl0xzG6x5HjcxUTTYPm4bJfIKezSHU0m-bjE93zFrYnEA219SNzMLpf3A_3kvufZx8chUTBpCXTGjnozRjp_uE_Z7aePN5dfiuuvn68uV9eFrQFSYcsWG9E1qsMGVd5MSrCqd6gsQE1N3fa27akncKo0LZaOEEFaq2pFFpw4ZVcHrvNmo7dhmEzYaW8G_VvwYa1NSIMdSVtAQ04Qmb6qZKVUl4-jUlROyqYzmfXhwNou3UTO0pyCGZ9Bn7_Mw51e-3uNUGVKVWXC2wdC8D8Wiklv_BLm_AG6bEtAVbWI2YUHlw0-xkD94wgEvc9X_5Nv7nnzdLfHjj9pZsPFwRDNmv6O_T_xFzaNrng</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Landells, Fiona M</creator><creator>Vender, Ronald</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><general>SAGE Publishing</general><scope>AFRWT</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230101</creationdate><title>Adalimumab-induced systemic lupus erythematosus: A case report and review of the literature</title><author>Landells, Fiona M ; Vender, Ronald</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-c29163b68b1618758770c8fd18c005e659fc9fefe0d82a912de1107cc858ec0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>JCMS Case Report</topic><topic>Lupus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Landells, Fiona M</creatorcontrib><creatorcontrib>Vender, Ronald</creatorcontrib><collection>SAGE Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>SAGE open medical case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Landells, Fiona M</au><au>Vender, Ronald</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adalimumab-induced systemic lupus erythematosus: A case report and review of the literature</atitle><jtitle>SAGE open medical case reports</jtitle><addtitle>SAGE Open Med Case Rep</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>11</volume><spage>2050313X231193077</spage><pages>2050313X231193077-</pages><issn>2050-313X</issn><eissn>2050-313X</eissn><abstract>Adalimumab is a tumor necrosis factor inhibitor that has been widely used since the early 2000s for the treatment of psoriasis and psoriatic arthritis. All tumor necrosis factor inhibitors have been identified as causative agents in drug induced lupus, particularly etanercept and infliximab. There have been few reported cases of systemic lupus erythematosus induced by adalimumab, many more are attributable to treatment with etanercept or infliximab. We present the case of a patient with long-standing psoriasis and psoriatic arthritis who was successfully treated with adalimumab, but developed anti-tumor necrosis factor-induced lupus.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>37581114</pmid><doi>10.1177/2050313X231193077</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2050-313X
ispartof SAGE open medical case reports, 2023-01, Vol.11, p.2050313X231193077
issn 2050-313X
2050-313X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c01aed3eeaf447488b488de234d776ba
source SAGE Open Access; Publicly Available Content Database; PubMed Central
subjects JCMS Case Report
Lupus
title Adalimumab-induced systemic lupus erythematosus: A case report and review of the literature
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A59%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adalimumab-induced%20systemic%20lupus%20erythematosus:%20A%20case%20report%20and%20review%20of%20the%20literature&rft.jtitle=SAGE%20open%20medical%20case%20reports&rft.au=Landells,%20Fiona%20M&rft.date=2023-01-01&rft.volume=11&rft.spage=2050313X231193077&rft.pages=2050313X231193077-&rft.issn=2050-313X&rft.eissn=2050-313X&rft_id=info:doi/10.1177/2050313X231193077&rft_dat=%3Cproquest_doaj_%3E2920184911%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c500t-c29163b68b1618758770c8fd18c005e659fc9fefe0d82a912de1107cc858ec0d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2920184911&rft_id=info:pmid/37581114&rft_sage_id=10.1177_2050313X231193077&rfr_iscdi=true